Pacific Biosciences Of California (PACB) Change in Inventory (2011 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Change in Inventory of $3.2 million for Q1 2026, up 26.32% year-over-year from $2.5 million in Q1 2025, and up 191.42% quarter-over-quarter from -$3.5 million in Q4 2025.
Pacific Biosciences Of California (PACB) Change in Inventory (2011 - 2026) Analysis & Trends
Pacific Biosciences Of California's Change in Inventory history runs 16 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 26.32% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $2.1 million (up 361.86% YoY), while the FY2025 annual figure was $1.4 million, down 82.94% from the prior year.
- Change in Inventory for Q1 2026 stood at $3.2 million, up from -$3.5 million in the prior quarter.
- The five-year high for Change in Inventory was $13.3 million in Q1 2023, with the low at -$9.0 million in Q4 2023.
- The 5-year median for Change in Inventory is $3.2 million (2026), against an average of $3.6 million.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory soared 235.25% in 2022, then tumbled 185.47% in 2023.
- Pacific Biosciences Of California's Change in Inventory stood at $10.5 million in 2022, then sank by 185.47% to -$9.0 million in 2023, then grew by 21.47% to -$7.1 million in 2024, then jumped by 50.42% to -$3.5 million in 2025, then soared by 191.42% to $3.2 million in 2026.
- Business Quant data shows PACB's Change in Inventory at $3.2 million in Q1 2026, -$3.5 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 301.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 113.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 133.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 23.50 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 36.40 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 139.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -131.35 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 73.30 Mn |
| 10 | Pacific Biosciences Of California | 394.84 Mn | 157.97 Mn | 12.64 Mn | 11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.26 Mn |
| Jun 30, 2026 | 11.26 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | -3.51 Mn |
| Dec 31, 2025 | -3.51 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | -7.07 Mn |
| Dec 31, 2024 | -7.07 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | 11.66 Mn |
| Mar 31, 2024 | 11.66 Mn |